Acute Myeloid Leukemia Post Cytotoxic Therapy
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia Post Cytotoxic Therapy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) [Phase 2]
Phase 2 clinical trial update for a study evaluating novel therapeutics in newly diagnosed high-risk acute myeloid leukemia; the trial is cu…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia [Phase 1]
Phase I trial evaluating AZD1775 in combination with belinostat for relapsed or refractory myeloid malignancies or untreated acute myeloid l…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 randomized trial evaluating pembrolizumab added to azacitidine and venetoclax as frontline therapy for unfit acute myeloid leukemia …